详细解释: Dotarem:钆特酸葡胺注射剂 钆特酸葡胺(gadoterate meglumine)是FDA批准的第7个含钆造影剂,用于中枢神经系统的磁共振成像(MRI),前6个同类药物分别是Magnevist、Prohance、Omniscan、Optimark、Multihance、Gadavist。以下为句子列表:分享到: 赞助...
英文名:gadoterate meglumine 药品价格:HK$ 请咨询微信客服 研发公司:Guerbet 适用症:CNS系统MRI造影剂 型号规格:0.5mmol/ml 药品详情: 多他灵(Dotarem,钆特酸葡胺)用于核磁共振成像造影,属一类医学辅助制剂。 注:药品如有新包装,以新包装为准。以上资讯来源于网络或由高等医药院校的学生志愿者翻译(如有错漏,请...
2013年3月20日,美国食品药品监督管理局(FDA)宣布,批准Dotarem(多它灵,gadoterate meglumine,钆特酸葡胺)用于2岁以上人群中大脑、脊椎和相关组织的磁共振成像(MRI)。 2013年3月20日,美国食品药品监督管理局(FDA)宣布,批准Dotarem(多它灵,gadoterate meglumine,钆特酸葡胺)用于2岁以上人群中大脑、脊椎和相关组织的磁共...
Dotarem®(gadoterate meglumine) injection is an ionic, macrocyclic gadolinium-based contrast agent (GBCA). The first marketing authorization of Dotarem®was approved in 2013 in the United States.2Since then, Dotarem®has been used in clinical practice, delivering effective MR contrast-enhanced exa...
Generic name: gadoterate meglumineDosage form: InjectionCompany: GuerbetTreatment for: Diagnosis and InvestigationDotarem (gadoterate meglumine) is a gadolinium-based contrast agent indicated for use in magnetic resonance imaging (MRI). Development timeline for Dotarem...
Dotarem(gadoterate meglumine) Eovist(gadoxetate disodium) Gadavist(gadobutrol) Magnevist(gadopentetate dimeglumine) MultiHance(gadobenate dimeglumine) Omniscan(gadodiamide) OptiMARK (gadoversetamide) ProHance(gadoteridol) All GBCAs may be associated with some gadolinium retention in the brain and other bo...
(HealthDay)—Dotarem (gadoterate meglumine) has been approved by the U.S. Food and Drug Administration as a contrast agent for use in MRIs of the brain, spine and other parts of the central nervous system. Approved for people two years and older, the imaging agent helps radiologists detect...
Anzalone N, Scarabino T, Venturi C, et al. Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting. Eur J Radiol 2013;82:139 –45. ...
网络多它灵;葡甲胺 网络释义
Retention is lowest and similar among the macrocyclic GBCAs [Dotarem (gadoterate meglumine), Gadavist (gadobutrol), ProHance (gadoteridol)]. Consequences of gadolinium retention in the brain have not been established. Pathologic and clinical consequences of GBCA administration and retention in skin ...